Diverse roles for T-bet in the effector responses required for resistance to infection

Journal of Immunology

Volumn 194, Issue 3, 2015, Pages 1131-1140

  Pritchard, Gretchen Harms ^a   Hall, Aisling O'Hara ^a   Christian, David A ^a   Wagage, Sagie ^a   Fang, Qun ^a   Muallem, Gaia ^a   John, Beena ^a   Zaretsky, Arielle Glatman ^a   Dunn, William G ^a   Perrigoue, Jacqueline ^a   Reiner, Steven L ^b   Hunter, Christopher A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTEGRIN; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; INTERLEUKIN 2; KLRG 1 PROTEIN; LY6C PROTEIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; T LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG; T BOX TRANSCRIPTION FACTOR; T-BOX TRANSCRIPTION FACTOR TBX21;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; EFFECTOR CELL; IMMUNE RESPONSE; INFECTION RESISTANCE; INNATE IMMUNITY; LYMPHOCYTE FUNCTION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PARASITE CONTROL; PARASITE LOAD; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; TOXOPLASMA GONDII; ANIMAL; ANIMAL TOXOPLASMOSIS; DISEASE MODEL; DISEASE RESISTANCE; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; IMMUNITY; IMMUNOLOGY; IMMUNOPHENOTYPING; INFECTION; KNOCKOUT MOUSE; METABOLISM; NATURAL KILLER CELL; PARASITOLOGY; PHENOTYPE; T LYMPHOCYTE SUBPOPULATION; TOXOPLASMA;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE RESISTANCE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY; IMMUNITY, CELLULAR; IMMUNITY, INNATE; IMMUNOPHENOTYPING; INFECTION; KILLER CELLS, NATURAL; MICE; MICE, KNOCKOUT; PHENOTYPE; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTE SUBSETS; TOXOPLASMA; TOXOPLASMOSIS, ANIMAL;

EID: 84921456080     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401617     Document Type: Article

References (72)

1. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
2. Szabo, S. J., B. M. Sullivan, C. Stemmann, A. R. Satoskar, B. P. Sleckman, and L. H. Glimcher. 2002. Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 295: 338-342.
3. Lugo-Villarino, G., R. Maldonado-Lopez, R. Possemato, C. Penaranda, and L. H. Glimcher. 2003. T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc. Natl. Acad. Sci. USA 100: 7749-7754.
4. Lugo-Villarino, G., S. Ito, D. M. Klinman, and L. H. Glimcher. 2005. The adjuvant activity of CpG DNA requires T-bet expression in dendritic cells. Proc. Natl. Acad. Sci. USA 102: 13248-13253.
5. Pearce, E. L., A. C. Mullen, G. A. Martins, C. M. Krawczyk, A. S. Hutchins, V. P. Zediak, M. Banica, C. B. DiCioccio, D. A. Gross, C. A. Mao, et al. 2003. Control of effector CD8+ T cell function by the transcription factor Eomesodermin. Science 302: 1041-1043.
6. Sullivan, B. M., A. Juedes, S. J. Szabo, M. von Herrath, and L. H. Glimcher. 2003. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc. Natl. Acad. Sci. USA 100: 15818-15823.
7. Juedes, A. E., E. Rodrigo, L. Togher, L. H. Glimcher, and M. G. von Herrath. 2004. T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J. Exp. Med. 199: 1153-1162.
8. Townsend, M. J., A. S. Weinmann, J. L. Matsuda, R. Salomon, P. J. Farnham, C. A. Biron, L. Gapin, and L. H. Glimcher. 2004. T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20: 477-494.
9. Intlekofer, A. M., A. Banerjee, N. Takemoto, S. M. Gordon, C. S. Dejong, H. Shin, C. A. Hunter, E. J. Wherry, T. Lindsten, and S. L. Reiner. 2008. Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science 321: 408-411.
10. Gordon, S. M., J. Chaix, L. J. Rupp, J. Wu, S. Madera, J. C. Sun, T. Lindsten, and S. L. Reiner. 2012. The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 36: 55-67.
11. Mathur, A. N., H. C. Chang, D. G. Zisoulis, R. Kapur, M. L. Belladonna, G. S. Kansas, and M. H. Kaplan. 2006. T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 108: 1595-1601.
12. Lord, G. M., R. M. Rao, H. Choe, B. M. Sullivan, A. H. Lichtman, F. W. Luscinskas, and L. H. Glimcher. 2005. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106: 3432-3439.
13. Ravindran, R., J. Foley, T. Stoklasek, L. H. Glimcher, and S. J. McSorley. 2005. Expression of T-bet by CD4 T cells is essential for resistance to Salmonella infection. J. Immunol. 175: 4603-4610.
14. Sullivan, B. M., O. Jobe, V. Lazarevic, K. Vasquez, R. Bronson, L. H. Glimcher, and I. Kramnik. 2005. Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production. J. Immunol. 175: 4593-4602.
15. Svensson, A., I. Nordström, J. B. Sun, and K. Eriksson. 2005. Protective immunity to genital herpes simplex [correction of simpex] virus type 2 infection is mediated by T-bet. J. Immunol. 174: 6266-6273.
16. Way, S. S., and C. B. Wilson. 2004. Cutting edge: immunity and IFN-gamma production during Listeria monocytogenes infection in the absence of T-bet. J. Immunol. 173: 5918-5922.
17. Intlekofer, A. M., N. Takemoto, E. J. Wherry, S. A. Longworth, J. T. Northrup, V. R. Palanivel, A. C. Mullen, C. R. Gasink, S. M. Kaech, J. D. Miller, et al. 2005. Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin. Nat. Immunol. 6: 1236-1244.
18. Gazzinelli, R. T., F. T. Hakim, S. Hieny, G. M. Shearer, and A. Sher. 1991. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. J. Immunol. 146: 286-292.
19. Khan, I. A., T. Matsuura, and L. H. Kasper. 1994. Interleukin-12 enhances murine survival against acute toxoplasmosis. Infect. Immun. 62: 1639-1642.
20. Sher, A., C. Collazzo, C. Scanga, D. Jankovic, G. Yap, and J. Aliberti. 2003. Induction and regulation of IL-12-dependent host resistance to Toxoplasma gondii. Immunol. Res. 27: 521-528.
21. Lieberman, L. A., M. Banica, S. L. Reiner, and C. A. Hunter. 2004. STAT1 plays a critical role in the regulation of antimicrobial effector mechanisms, but not in the development of Th1-type responses during toxoplasmosis. J. Immunol. 172: 457-463.
22. Zhu, J., D. Jankovic, A. J. Oler, G. Wei, S. Sharma, G. Hu, L. Guo, R. Yagi, H. Yamane, G. Punkosdy, et al. 2012. The transcription factor T-bet is induced by multiple pathways and prevents an endogenous Th2 cell program during Th1 cell responses. Immunity. 37: 660-673.
23. Taylor, G. A. 2007. IRG proteins: key mediators of interferon-regulated host resistance to intracellular pathogens. Cell. Microbiol. 9: 1099-1107.
24. MacMicking, J. D. 2012. Interferon-inducible effector mechanisms in cell-autonomous immunity. Nat. Rev. Immunol. 12: 367-382.
25. Hauser, W. E., Jr., S. D. Sharma, and J. S. Remington. 1983. Augmentation of NK cell activity by soluble and particulate fractions of Toxoplasma gondii. J. Immunol. 131: 458-463.
26. Wille, U., M. Nishi, L. Lieberman, E. H. Wilson, D. S. Roos, and C. A. Hunter. 2004. IL-10 is not required to prevent immune hyperactivity during memory responses to Toxoplasma gondii. Parasite Immunol. 26: 229-236.
27. Roederer, M., J. L. Nozzi, and M. C. Nason. 2011. SPICE: exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 79: 167-174.
28. Joshi, N. S., W. Cui, A. Chandele, H. K. Lee, D. R. Urso, J. Hagman, L. Gapin, and S. M. Kaech. 2007. Inflammation directs memory precursor and short-lived effector CD8(+) T cell fates via the graded expression of T-bet transcription factor. Immunity 27: 281-295.
29. Wilson, D. C., S. Matthews, and G. S. Yap. 2008. IL-12 signaling drives CD8+ T cell IFN-gamma production and differentiation of KLRG1+ effector subpopulations during Toxoplasma gondii Infection. J. Immunol. 180: 5935-5945.
30. Marshall, H. D., A. Chandele, Y. W. Jung, H. Meng, A. C. Poholek, I. A. Parish, R. Rutishauser, W. Cui, S. H. Kleinstein, J. Craft, and S. M. Kaech. 2011. Differential expression of Ly6C and T-bet distinguish effector and memory Th1 CD4(+) cell properties during viral infection. Immunity 35: 633-646.
31. Srinivasan, A., J. Foley, and S. J. McSorley. 2004. Massive number of antigenspecific CD4 T cells during vaccination with live attenuated Salmonella causes interclonal competition. J. Immunol. 172: 6884-6893.
32. Rai, D., N. L. Pham, J. T. Harty, and V. P. Badovinac. 2009. Tracking the total CD8 T cell response to infection reveals substantial discordance in magnitude and kinetics between inbred and outbred hosts. J. Immunol. 183: 7672-7681.
33. McDermott, D. S., and S. M. Varga. 2011. Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we think. J. Immunol. 187: 5568-5576.
34. Dupont, C. D., D. A. Christian, E. M. Selleck, M. Pepper, M. Leney-Greene, G. Harms Pritchard, A. A. Koshy, S. Wagage, M. A. Reuter, L. D. Sibley, et al. 2014. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathog. 10: e1004047.
35. Grover, H. S., N. Blanchard, F. Gonzalez, S. Chan, E. A. Robey, and N. Shastri. 2012. The Toxoplasma gondii peptide AS15 elicits CD4 T cells that can control parasite burden. Infect. Immun. 80: 3279-3288.
36. Wilson, D. C., G. M. Grotenbreg, K. Liu, Y. Zhao, E. M. Frickel, M. J. Gubbels, H. L. Ploegh, and G. S. Yap. 2010. Differential regulation of effector- and central-memory responses to Toxoplasma gondii Infection by IL-12 revealed by tracking of Tgd057-specific CD8+ T cells. PLoS Pathog. 6: e1000815.
37. McLane, L. M., P. P. Banerjee, G. L. Cosma, G. Makedonas, E. J. Wherry, J. S. Orange, and M. R. Betts. 2013. Differential localization of T-bet and Eomes in CD8 T cell memory populations. J. Immunol. 190: 3207-3215.
38. Suzuki, Y., M. A. Orellana, R. D. Schreiber, and J. S. Remington. 1988. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240: 516-518.
39. Scharton-Kersten, T. M., T. A. Wynn, E. Y. Denkers, S. Bala, E. Grunvald, S. Hieny, R. T. Gazzinelli, and A. Sher. 1996. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol. 157: 4045-4054.
40. Gazzinelli, R. T., M. Wysocka, S. Hieny, T. Scharton-Kersten, A. Cheever, R. Kühn, W. Müller, G. Trinchieri, and A. Sher. 1996. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J. Immunol. 157: 798-805.
41. Liesenfeld, O., J. Kosek, J. S. Remington, and Y. Suzuki. 1996. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii. J. Exp. Med. 184: 597-607.
42. Villarino, A., L. Hibbert, L. Lieberman, E. Wilson, T. Mak, H. Yoshida, R. A. Kastelein, C. Saris, and C. A. Hunter. 2003. The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. Immunity 19: 645-655.
43. Kugler, D. G., P. R. Mittelstadt, J. D. Ashwell, A. Sher, and D. Jankovic. 2013. CD4+ T cells are trigger and target of the glucocorticoid response that prevents lethal immunopathology in toxoplasma infection. J. Exp. Med. 210: 1919-1927.
44. Hunter, C. A., C. S. Subauste, V. H. Van Cleave, and J. S. Remington. 1994. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect. Immun. 62: 2818-2824.
45. Neyer, L. E., G. Grunig, M. Fort, J. S. Remington, D. Rennick, and C. A. Hunter. 1997. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii. Infect. Immun. 65: 1675-1682.
46. Lütjen, S., S. Soltek, S. Virna, M. Deckert, and D. Schlüter. 2006. Organ- and disease-stage-specific regulation of Toxoplasma gondii-specific CD8-T-cell responses by CD4 T cells. Infect. Immun. 74: 5790-5801.
47. Jordan, K. A., E. H. Wilson, E. D. Tait, B. A. Fox, D. S. Roos, D. J. Bzik, F. Dzierszinski, and C. A. Hunter. 2009. Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii. Infect. Immun. 77: 3894-3901.
48. Mosmann, T. R., and R. L. Coffman. 1987. Two types of mouse helper T-cell clone Implications for immune regulation. Immunol. Today 8: 223-227.
49. Johnson, L. L., F. P. VanderVegt, and E. A. Havell. 1993. Gamma interferon-dependent temporary resistance to acute Toxoplasma gondii infection independent of CD4+ or CD8+ lymphocytes. Infect. Immun. 61: 5174-5180.
50. Casciotti, L., K. H. Ely, M. E. Williams, and I. A. Khan. 2002. CD8(+)-T-cell immunity against Toxoplasma gondii can be induced but not maintained in mice lacking conventional CD4(+) T cells. Infect. Immun. 70: 434-443.
51. Mayer, K. D., K. Mohrs, W. Reiley, S. Wittmer, J. E. Kohlmeier, J. E. Pearl, A. M. Cooper, L. L. Johnson, D. L. Woodland, and M. Mohrs. 2008. Cutting edge: T-bet and IL-27R are critical for in vivo IFN-gamma production by CD8 T cells during infection. J. Immunol. 180: 693-697.
52. Lieberman, L. A., and C. A. Hunter. 2002. The role of cytokines and their signaling pathways in the regulation of immunity to Toxoplasma gondii. Int. Rev. Immunol. 21: 373-403.
53. Korbel, D. S., O. C. Finney, and E. M. Riley. 2004. Natural killer cells and innate immunity to protozoan pathogens. Int. J. Parasitol. 34: 1517-1528.
54. Lodoen, M. B., and L. L. Lanier. 2006. Natural killer cells as an initial defense against pathogens. Curr. Opin. Immunol. 18: 391-398.
55. Koch, M. A., G. Tucker-Heard, N. R. Perdue, J. R. Killebrew, K. B. Urdahl, and D. J. Campbell. 2009. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat. Immunol. 10: 595-602.
56. Khan, I. A., J. A. MacLean, F. S. Lee, L. Casciotti, E. DeHaan, J. D. Schwartzman, and A. D. Luster. 2000. IP-10 is critical for effector T cell trafficking and host survival in Toxoplasma gondii infection. Immunity 12: 483-494.
57. Fadel, S. A., S. K. Bromley, B. D. Medoff, and A. D. Luster. 2008. CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality. Eur. J. Immunol. 38: 3376-3387.
58. Lindell, D. M., T. E. Lane, and N. W. Lukacs. 2008. CXCL10/CXCR3-mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy. Eur. J. Immunol. 38: 2168-2179.
59. + T cells are required to activate inflammatory monocytes for defense against intestinal infection. PLoS Pathog. 9: e1003706.
60. Villegas, E. N., U. Wille, L. Craig, P. S. Linsley, D. M. Rennick, R. Peach, and C. A. Hunter. 2000. Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice. Infect. Immun. 68: 2837-2844.
61. Wille, U., E. N. Villegas, L. Craig, R. Peach, and C. A. Hunter. 2002. Contribution of interleukin-12 (IL-12) and the CD28/B7 and CD40/CD40 ligand pathways to the development of a pathological T-cell response in IL-10-deficient mice. Infect. Immun. 70: 6940-6947.
62. Campanella, G. S., A. M. Tager, J. K. El Khoury, S. Y. Thomas, T. A. Abrazinski, L. A. Manice, R. A. Colvin, and A. D. Luster. 2008. Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria. Proc. Natl. Acad. Sci. USA 105: 4814-4819.
63. Oakley, M. S., B. R. Sahu, L. Lotspeich-Cole, N. R. Solanki, V. Majam, P. T. Pham, R. Banerjee, Y. Kozakai, S. C. Derrick, S. Kumar, and S. L. Morris. 2013. The transcription factor T-bet regulates parasitemia and promotes pathogenesis during Plasmodium berghei ANKA murine malaria. J. Immunol. 191: 4699-4708.
64. Peng, S. L. 2006. The T-box transcription factor T-bet in immunity and auto-immunity. Cell. Mol. Immunol. 3: 87-95.
65. Neurath, M. F., B. Weigmann, S. Finotto, J. Glickman, E. Nieuwenhuis, H. Iijima, A. Mizoguchi, E. Mizoguchi, J. Mudter, P. R. Galle, et al. 2002. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195: 1129-1143.
66. Chang, J. T., M. L. Ciocca, I. Kinjyo, V. R. Palanivel, C. E. McClurkin, C. S. Dejong, E. C. Mooney, J. S. Kim, N. C. Steinel, J. Oliaro, et al. 2011. Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. Immunity 34: 492-504.
67. Jang, E. J., H. R. Park, J. H. Hong, and E. S. Hwang. 2013. Lysine 313 of T-box is crucial for modulation of protein stability, DNA binding, and threonine phosphorylation of T-bet. J. Immunol. 190: 5764-5770.
68. Bose, T. O., Q. M. Pham, E. R. Jellison, J. Mouries, C. M. Ballantyne, and L. Lefrançois. 2013. CD11a regulates effector CD8 T cell differentiation and central memory development in response to infection with Listeria monocytogenes. Infect. Immun. 81: 1140-1151.
69. Gérard, A., O. Khan, P. Beemiller, E. Oswald, J. Hu, M. Matloubian, and M. F. Krummel. 2013. Secondary T cell-T cell synaptic interactions drive the differentiation of protective CD8+ T cells. Nat. Immunol. 14: 356-363.
70. Groom, J. R., J. Richmond, T. T. Murooka, E. W. Sorensen, J. H. Sung, K. Bankert, U. H. von Andrian, J. J. Moon, T. R. Mempel, and A. D. Luster. 2012. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity 37: 1091-1103.
71. Harris, T. H., E. J. Banigan, D. A. Christian, C. Konradt, E. D. Tait Wojno, K. Norose, E. H. Wilson, B. John, W. Weninger, A. D. Luster, et al. 2012. Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells. Nature 486: 545-548.
72. Intlekofer, A. M., N. Takemoto, C. Kao, A. Banerjee, F. Schambach, J. K. Northrop, H. Shen, E. J. Wherry, and S. L. Reiner. 2007. Requirement for T-bet in the aberrant differentiation of unhelped memory CD8+ T cells. J. Exp. Med. 204: 2015-2021.